清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Airway Administration of Budesonide Combined With Pulmonary Surfactant to Prevent Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta‐Analysis

作者
Kaixu Wang,Dan Chen,Shuqiang Gao,Yue Guang,Rong Ju
出处
期刊:Pediatric Pulmonology [Wiley]
卷期号:60 (9): e71308-e71308
标识
DOI:10.1002/ppul.71308
摘要

ABSTRACT Objective To evaluate the effectiveness and safety of using budesonide in combination with pulmonary surfactant compared with the pulmonary surfactant alone in preventing bronchopulmonary dysplasia in preterm infants. Design Four databases (EMBASE, MEDLINE, Web of science, and Cochrane Central) were searched for randomized controlled trials comparing the use of intratracheal budesonide in combination with pulmonary surfactant to the use of pulmonary surfactant alone. Review manager 5.3 and Stata 17 software were used for statistical analysis. Main Outcomes Measures The primary outcome was the incidence of bronchopulmonary dysplasia in the group treated with budesonide combined with pulmonary surfactant, compared to the group treated with pulmonary surfactant alone. Secondary outcomes contained mortality rate, repeated use of pulmonary surfactant, length of hospital stay, and complications. Results 12 randomized controlled studies were included in this meta‐analysis, including 2428 preterm infants. Compared to the use of pulmonary surfactant alone, the combination of budesonide and pulmonary surfactant can significantly reduce the incidence of bronchopulmonary dysplasia ( p < 0.01, RR = 0.66, 95% CI: 0.53–0.84, low quality of evidence). Even after adjusting for the impact of publication bias, the results still indicate that the combination of budesonide and pulmonary surfactant significantly lowers the risk of BPD (RR = 0.77, 95% CI: 0.63–0.93). Additionally, it significantly decreases in‐hospital mortality rates in premature infants ( p = 0.02, RR = 0.80, 95% CI: 0.67–0.96, moderate quality of evidence), the incidence of pulmonary hemorrhage ( p < 0.01, RR = 0.61, 95% CI: 0.43–0.85, moderate quality of evidence), and the need of repeated use of pulmonary surfactant ( p < 0.01, RR = 0.52, 95% CI: 0.44–0.62, high quality of evidence). No statistically significant differences were observed in related complications. Conclusion Compared to the use of pulmonary surfactant alone, the combination of budesonide and pulmonary surfactant may prevent bronchopulmonary dysplasia in preterm infants, and does not increase the occurrence of related complications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
火柴盒完成签到,获得积分10
5秒前
漂亮的乐曲完成签到,获得积分10
32秒前
Maestro_S的应助被科研通管家采纳,获得10
39秒前
40秒前
40秒前
41秒前
urah发布了新的文献求助10
47秒前
愤怒的微笑完成签到,获得积分10
49秒前
宣灵薇完成签到 ,获得积分0
1分钟前
浮华乱世完成签到 ,获得积分10
1分钟前
风趣的莫英完成签到,获得积分10
1分钟前
沉默怡完成签到,获得积分10
1分钟前
Bonnie完成签到 ,获得积分10
1分钟前
liunahan完成签到 ,获得积分10
2分钟前
梅梅美美完成签到 ,获得积分10
2分钟前
丰富的从雪完成签到,获得积分10
2分钟前
天真的紫安完成签到,获得积分10
2分钟前
ss完成签到,获得积分10
2分钟前
Meera发布了新的文献求助30
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
hahasun完成签到,获得积分10
3分钟前
白奕完成签到,获得积分20
3分钟前
灵巧孤菱完成签到,获得积分10
3分钟前
ntxiaohu完成签到,获得积分10
3分钟前
义气的夏旋完成签到,获得积分10
3分钟前
3分钟前
不安荟完成签到,获得积分10
3分钟前
酷炫的又蓝完成签到,获得积分10
3分钟前
小云同学完成签到,获得积分10
3分钟前
Cosmosurfer完成签到,获得积分0
3分钟前
微笑宛儿完成签到,获得积分10
3分钟前
尊敬的千凡完成签到,获得积分10
4分钟前
飞哥与小佛完成签到,获得积分10
4分钟前
踏实雪卉完成签到,获得积分10
4分钟前
爱笑美女完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190226
求助须知:如何正确求助?哪些是违规求助? 9577355
关于积分的说明 21852358
捐赠科研通 7788741
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560106
邀请新用户注册赠送积分活动 2482902